— Know what they know.
Not Investment Advice

OCC.AX ASX

Orthocell Limited
1W: +2.7% 1M: +4.8% 3M: -12.6% YTD: -24.0% 1Y: -33.3% 3Y: +114.1% 5Y: +60.0%
A$0.74 ($0.52)
-0.02 (-2.61%)
 
Weekly Expected Move ±6.5%
A$1 A$1 A$1 A$1 A$1
ASX · Healthcare · Biotechnology · Tech Score Buy · Power 53 · A$207.0M mcap · 229M float · 0.141% daily turnover

📊 Key Metrics

TTM
A$18M
Revenue
+66.2% YoY
A$-22M
Net Income
-67.4% YoY
A$-23M
Free Cash Flow
-458.3% YoY
35.4%
Gross Margin
-159.8%
Op. Margin
-145.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-115.5%
ROA-55.2%
ROIC317.8%

Valuation

P/E-14.3
P/B6.0
EV/EBITDA-5.4

Leverage

Debt/Equity0.05
Current Ratio5.97
Interest Cov.0.0x

Quality Scores

Piotroski F3/9
Altman Z2.94
Beneish M-0.97

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms